Showing results (1781-1790 of 2,276) with videos related to
Sort By:
Pageof 228
Bioorganic & Medicinal Chemistry Letters|July 27, 2012
Synthesis and structure-activity relationships of dual PI3K/mTOR inhibitors based on a 4-amino-6-methyl-1,3,5-triazine sulfonamide scaffoldRyan P Wurz, Longbin Liu, Kevin Yang, et al.Multiple Sclerosis and Related Disorders|August 30, 2024
Associations between fatigue impact and physical and neurobehavioural factors: An exploration in people with progressive multiple sclerosisL Connolly, S Chatfield, J Freeman, et al.Journal of Autism and Developmental Disorders|June 1, 2000
Assessment in multisite randomized clinical trials of patients with autistic disorder: the Autism RUPP Network. Research Units on Pediatric PsychopharmacologyL E Arnold, M G Aman, A Martin, et al.Cell Reports|December 13, 2018
PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian CancerLiya Ding, Hye-Jung Kim, Qiwei Wang, et al.Journal of Autism and Developmental Disorders|August 8, 2020
The Importance of Professional Discourse for the Continual Advancement of Practice Standards: The RBT® as a Case in PointJustin B Leaf, Ronald Leaf, John McEachin, et al.Physical Review Letters|October 13, 2007
Effect of a triaxial nuclear shape on proton tunneling: the decay and structure of 145TmD Seweryniak, B Blank, M P Carpenter, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2016
PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict OutcomeMargaretha G M Roemer, Ranjana H Advani, Azra H Ligon, et al.Cancer Cell|September 13, 2017
Enhancing CD8<sup>+</sup> T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma ImmunotherapyYing Zhang, Raj Kurupati, Ling Liu, et al.Macromolecular Bioscience|October 11, 2014
Biocompatible, biodegradable and porous liquid crystal elastomer scaffolds for spatial cell culturesAnshul Sharma, Abdollah Neshat, Cory J Mahnen, et al.Nature Communications|June 17, 2026
IDH1-R132H enhances oncolytic HSV-1 therapy by facilitating viral entry and immune activation in gliomaEleni Panagioti, Hunter J Kelley, Alexander L Ling, et al.Pageof 228